Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Oral Oncol

Retrieve available abstracts of 278 articles:
HTML format
Text format



Single Articles


    April 2017
  1. RUEDA A, Giralt J, Manos M, Lozano A, et al
    Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2).
    Oral Oncol. 2017 Apr 17. pii: S1368-8375(17)30087.
    PubMed     Text format     Abstract available


  2. MANOS M, Giralt J, Rueda A, Cabrera J, et al
    Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).
    Oral Oncol. 2017 Apr 17. pii: S1368-8375(17)30088.
    PubMed     Text format     Abstract available


  3. AYUBI E, Safiri S
    Lateral lymph node recurrence after total thyroidectomy and central neck dissection in patients with papillary thyroid cancer without clinical evidence of lateral neck metastasis: Comment on data sparsity.
    Oral Oncol. 2017 Apr 17. pii: S1368-8375(17)30086.
    PubMed     Text format    


  4. YANG Q, Zou X, You R, Liu YP, et al
    Proposal for a new risk classification system for nasopharyngeal carcinoma patients with post-radiation nasopharyngeal necrosis.
    Oral Oncol. 2017;67:83-88.
    PubMed     Text format     Abstract available


  5. BORCHIELLINI D, Etienne-Grimaldi MC, Bensadoun RJ, Benezery K, et al
    Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer.
    Oral Oncol. 2017;67:70-76.
    PubMed     Text format     Abstract available


  6. HANNA GJ, Liu H, Jones RE, Bacay AF, et al
    Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck.
    Oral Oncol. 2017;67:61-69.
    PubMed     Text format     Abstract available


  7. OUYANG PY, Zhang LN, Xiao Y, Lan XW, et al
    Validation of published nomograms and accordingly individualized induction chemotherapy in nasopharyngeal carcinoma.
    Oral Oncol. 2017;67:37-45.
    PubMed     Text format     Abstract available


  8. PEREZ CA, Wu X, Amsbaugh MJ, Gosain R, et al
    High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neck.
    Oral Oncol. 2017;67:24-28.
    PubMed     Text format     Abstract available


  9. KINDT N, Descamps G, Seminerio I, Bellier J, et al
    High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma.
    Oral Oncol. 2017;67:183-191.
    PubMed     Text format     Abstract available


  10. POLESEL J, Furlan C, Birri S, Giacomarra V, et al
    The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.
    Oral Oncol. 2017;67:175-182.
    PubMed     Text format     Abstract available


  11. XIA WX, Liang H, Lv X, Wang L, et al
    Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysis.
    Oral Oncol. 2017;67:167-174.
    PubMed     Text format     Abstract available


  12. CHAU L, Jabara JT, Lai W, Svider PF, et al
    Topical agents for oral cancer chemoprevention: A systematic review of the literature.
    Oral Oncol. 2017;67:153-159.
    PubMed     Text format     Abstract available


  13. DE FELICE F, Guerrero Urbano T
    New drug development in head and neck squamous cell carcinoma: The PI3-K inhibitors.
    Oral Oncol. 2017;67:119-123.
    PubMed     Text format     Abstract available


  14. KADLETZ L, Thurnher D, Wiebringhaus R, Erovic BM, et al
    Role of cancer stem-cell marker doublecortin-like kinase 1 in head and neck squamous cell carcinoma.
    Oral Oncol. 2017;67:109-118.
    PubMed     Text format     Abstract available


  15. KOFLER B, Borena W, Manzl C, Dudas J, et al
    Sensitivity of tumor surface brushings to detect human papilloma virus DNA in head and neck cancer.
    Oral Oncol. 2017;67:103-108.
    PubMed     Text format     Abstract available


  16. RASTOGI M, Sapru S, Gupta P, Gandhi AK, et al
    Prospective evaluation of Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost (IMRT-SIB) in head and neck squamous cell carcinoma in patients not suitable for chemo-radiotherapy.
    Oral Oncol. 2017;67:10-16.
    PubMed     Text format     Abstract available


  17. HAMOIR M, Holvoet E, Ambroise J, Lengele B, et al
    Salvage surgery in recurrent head and neck squamous cell carcinoma: Oncologic outcome and predictors of disease free survival.
    Oral Oncol. 2017;67:1-9.
    PubMed     Text format     Abstract available


    March 2017
  18. BOONSTRA MC, Van Driel PB, Keereweer S, Prevoo HA, et al
    Preclinical uPAR-targeted multimodal imaging of locoregional oral cancer.
    Oral Oncol. 2017;66:1-8.
    PubMed     Text format     Abstract available


    February 2017
  19. PARK JS, Chang JW, Liu L, Jung SN, et al
    Clinical implications of microscopic extrathyroidal extension in patients with papillary thyroid carcinoma.
    Oral Oncol. 2017 Feb 17. pii: S1368-8375(17)30028.
    PubMed     Text format     Abstract available


  20. BELL RB, Gough MJ, Seung SK, Jutric Z, et al
    Erratum to 'Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy' [Oral Oncol. 61 (2016) 166-176].
    Oral Oncol. 2017 Feb 12. pii: S1368-8375(17)30021.
    PubMed     Text format    


  21. CAO W, Liu JN, Liu Z, Wang X, et al
    A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2017;65:94-101.
    PubMed     Text format     Abstract available


  22. MASSA ST, Osazuwa-Peters N, Christopher KM, Arnold LD, et al
    Competing causes of death in the head and neck cancer population.
    Oral Oncol. 2017;65:8-15.
    PubMed     Text format     Abstract available


  23. RIEKE K, Schmid KK, Lydiatt W, Houfek J, et al
    Depression and survival in head and neck cancer patients.
    Oral Oncol. 2017;65:76-82.
    PubMed     Text format     Abstract available


  24. KRISHNAN AR, Korrapati A, Zou AE, Qu Y, et al
    Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma.
    Oral Oncol. 2017;65:68-75.
    PubMed     Text format     Abstract available


  25. O'BRIEN KM, Timmons A, Butow P, Gooberman-Hill R, et al
    Associations between neighbourhood support and financial burden with unmet needs of head and neck cancer survivors.
    Oral Oncol. 2017;65:57-64.
    PubMed     Text format     Abstract available


  26. KAINULAINEN S, Tornwall J, Koivusalo AM, Suominen AL, et al
    Dexamethasone in head and neck cancer patients with microvascular reconstruction: No benefit, more complications.
    Oral Oncol. 2017;65:45-50.
    PubMed     Text format     Abstract available


    January 2017
  27. LUCHINI C, Veronese N
    The importance of extranodal extension in metastatic head and neck squamous cell carcinoma, in the light of the new AJCC cancer staging system.
    Oral Oncol. 2017 Jan 9. pii: S1368-8375(16)30279.
    PubMed     Text format    


  28. SWICK AD, Stein AP, McCulloch TM, Hartig GK, et al
    Defining the boundaries and expanding the utility of head and neck cancer patient derived xenografts.
    Oral Oncol. 2017;64:65-72.
    PubMed     Text format     Abstract available


  29. BRAVI F, Polesel J, Garavello W, Serraino D, et al
    Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and head and neck cancers risk.
    Oral Oncol. 2017;64:59-64.
    PubMed     Text format     Abstract available


  30. VAN DEUDEKOM FJ, Schimberg AS, Kallenberg MH, Slingerland M, et al
    Functional and cognitive impairment, social environment, frailty and adverse health outcomes in older patients with head and neck cancer, a systematic review.
    Oral Oncol. 2017;64:27-36.
    PubMed     Text format     Abstract available


  31. LIU YC, Wang WY, Twu CW, Jiang RS, et al
    Prognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patients.
    Oral Oncol. 2017;64:15-21.
    PubMed     Text format     Abstract available


  32. MORONEY LB, Helios J, Ward EC, Crombie J, et al
    Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT+/-concurrent chemotherapy.
    Oral Oncol. 2017;64:1-8.
    PubMed     Text format     Abstract available


    December 2016
  33. D'SOUZA G, Anantharaman D, Gheit T, Abedi-Ardekani B, et al
    Corrigendum to 'Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents' [Oral Oncol. 62 (2016) 20-27].
    Oral Oncol. 2016 Dec 30. pii: S1368-8375(16)30270.
    PubMed     Text format    


  34. GALVAO-MOREIRA LV, da Cruz MC
    Corrigendum to "Oral microbiome, periodontitis and risk of head and neck cancer" [Oral Oncol. 53 (2016) 17-19].
    Oral Oncol. 2016 Dec 23. pii: S1368-8375(16)30266.
    PubMed     Text format    


  35. LI YJ, Lai WT, Chang CC, Kuo MY, et al
    Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression.
    Oral Oncol. 2016 Dec 21. pii: S1368-8375(16)30214.
    PubMed     Text format     Abstract available


  36. YAMAMOTO VN, Thylur DS, Bauschard M, Schmale I, et al
    Overcoming radioresistance in head and neck squamous cell carcinoma.
    Oral Oncol. 2016;63:44-51.
    PubMed     Text format     Abstract available


  37. FERNANDEZ-MATEOS J, Seijas-Tamayo R, Mesia R, Taberna M, et al
    Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population.
    Oral Oncol. 2016;63:38-43.
    PubMed     Text format     Abstract available


  38. INGLEHART RC, Taberna M, Pickard RK, Hoff M, et al
    HPV knowledge gaps and information seeking by oral cancer patients.
    Oral Oncol. 2016;63:23-29.
    PubMed     Text format     Abstract available


  39. PATIL V, Joshi A, Noronha V, Deodhar J, et al
    Expectations and preferences for palliative chemotherapy in head and neck cancers patients.
    Oral Oncol. 2016;63:10-15.
    PubMed     Text format     Abstract available


    November 2016
  40. DASTE A, de Mones E, Digue L, Francois L, et al
    Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatment.
    Oral Oncol. 2016 Nov 3. pii: S1368-8375(16)30196.
    PubMed     Text format    


  41. PENG H, Chen L, Li WF, Zhang Y, et al
    Optimize the cycle of neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: A propensity score matching analysis.
    Oral Oncol. 2016;62:78-84.
    PubMed     Text format     Abstract available


  42. LIU L, Chang JW, Jung SN, Park HS, et al
    Clinical implications of the extent of BRAFV600E alleles in patients with papillary thyroid carcinoma.
    Oral Oncol. 2016;62:72-77.
    PubMed     Text format     Abstract available


  43. MERMOD M, Tolstonog G, Simon C, Monnier Y, et al
    Extracapsular spread in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Oral Oncol. 2016;62:60-71.
    PubMed     Text format     Abstract available


  44. DEL BARCO MORILLO E, Mesia R, Adansa Klain JC, Vazquez Fernandez S, et al
    Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study.
    Oral Oncol. 2016;62:54-59.
    PubMed     Text format     Abstract available


  45. BLANCHARD P, Volk RJ, Ringash J, Peterson SK, et al
    Assessing head and neck cancer patient preferences and expectations: A systematic review.
    Oral Oncol. 2016;62:44-53.
    PubMed     Text format     Abstract available


  46. CHENG SJ, Chang CF, Lee JJ, Chen HM, et al
    Hypermethylated ZNF582 and PAX1 are effective biomarkers for detection of oral dysplasia and oral cancer.
    Oral Oncol. 2016;62:34-43.
    PubMed     Text format     Abstract available


  47. SWARTZ JE, Pothen AJ, Wegner I, Smid EJ, et al
    Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
    Oral Oncol. 2016;62:28-33.
    PubMed     Text format     Abstract available


  48. D'SOUZA G, Anantharaman D, Gheit T, Abedi-Ardekani B, et al
    Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents.
    Oral Oncol. 2016;62:20-27.
    PubMed     Text format     Abstract available


  49. KUO TJ, Chu CH, Tang PL, Lai YC, et al
    Effects of geographic area and socioeconomic status in Taiwan on survival rates of head and neck cancer patients after radiotherapy.
    Oral Oncol. 2016;62:136-138.
    PubMed     Text format    


  50. NAIK PP, Das DN, Panda PK, Mukhopadhyay S, et al
    Implications of cancer stem cells in developing therapeutic resistance in oral cancer.
    Oral Oncol. 2016;62:122-135.
    PubMed     Text format     Abstract available


  51. OU D, Blanchard P, El Khoury C, De Felice F, et al
    Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma.
    Oral Oncol. 2016;62:114-121.
    PubMed     Text format     Abstract available


  52. LIM YC, Liu L, Chang JW, Koo BS, et al
    Lateral lymph node recurrence after total thyroidectomy and central neck dissection in patients with papillary thyroid cancer without clinical evidence of lateral neck metastasis.
    Oral Oncol. 2016;62:109-113.
    PubMed     Text format     Abstract available


  53. KINDT N, Descamps G, Seminerio I, Bellier J, et al
    Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas.
    Oral Oncol. 2016;62:1-10.
    PubMed     Text format     Abstract available


    October 2016
  54. EDER-CZEMBIREK C, Czembirek C, Selzer E
    Erratum to "Neoadjuvant radiotherapy plus radical surgery for locally advanced stage III/IV oral cancer: Analysis of prognostic factors affecting overall survival" [Oral Oncol. 60 (2016) 1-7].
    Oral Oncol. 2016 Oct 31. pii: S1368-8375(16)30192.
    PubMed     Text format    


  55. LOW GM, Thylur DS, Yamamoto V, Sinha UK, et al
    Erratum to "The effect of human papillomavirus on DNA repair in head and neck squamous cell carcinoma" [Oral Oncol. 61 (2016) 27-30].
    Oral Oncol. 2016 Oct 31. pii: S1368-8375(16)30193.
    PubMed     Text format    


  56. BAXI SS, Dunn LA, Burtness BA
    Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma.
    Oral Oncol. 2016 Oct 21. pii: S1368-8375(16)30182.
    PubMed     Text format    


  57. ZOLKIND P, Dunn GP, Lin T, Griffith M, et al
    Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma.
    Oral Oncol. 2016 Oct 14. pii: S1368-8375(16)30175.
    PubMed     Text format     Abstract available


  58. MATHIALAGAN A, Verma RK, Panda NK
    Comparison of spinal accessory dysfunction following neck dissection with harmonic scalpel and electrocautery - A randomized study.
    Oral Oncol. 2016;61:142-5.
    PubMed     Text format     Abstract available


  59. ADHAULIYA N, Kalappanavar AN, Ali IM, Annigeri RG, et al
    Autophagy: A boon or bane in oral cancer.
    Oral Oncol. 2016;61:120-6.
    PubMed     Text format     Abstract available


  60. DIVI V, Tao L, Whittemore A, Oakley-Girvan I, et al
    Geographic variation in Medicare treatment costs and outcomes for advanced head and neck cancer.
    Oral Oncol. 2016;61:83-8.
    PubMed     Text format     Abstract available


  61. HAGEDOORN P, Vandenheede H, Vanthomme K, Willaert D, et al
    A cohort study into head and neck cancer mortality in Belgium (2001-11): Are individual socioeconomic differences conditional on area deprivation?
    Oral Oncol. 2016;61:76-82.
    PubMed     Text format     Abstract available


  62. PURKAYASTHA M, McMahon AD, Gibson J, Conway DI, et al
    Trends of oral cavity, oropharyngeal and laryngeal cancer incidence in Scotland (1975-2012) - A socioeconomic perspective.
    Oral Oncol. 2016;61:70-5.
    PubMed     Text format     Abstract available


  63. CHAMCHOD S, Fuller CD, Mohamed AS, Grossberg A, et al
    Quantitative body mass characterization before and after head and neck cancer radiotherapy: A challenge of height-weight formulae using computed tomography measurement.
    Oral Oncol. 2016;61:62-9.
    PubMed     Text format     Abstract available


  64. FIGUEIREDO RA, Weiderpass E, Tajara EH, Strom P, et al
    Diabetes mellitus, metformin and head and neck cancer.
    Oral Oncol. 2016;61:47-54.
    PubMed     Text format     Abstract available


  65. WIRTH LJ, Dakhil S, Kornek G, Axelrod R, et al
    PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Oral Oncol. 2016;61:31-40.
    PubMed     Text format     Abstract available


  66. LOW GM, Thylur DS, N Yamamoto V, Sinha UK, et al
    The effect of human papillomavirus on DNA repair in head and neck squamous cell carcinoma.
    Oral Oncol. 2016;61:27-30.
    PubMed     Text format     Abstract available


  67. SINEVICI N, O'sullivan J
    Oral cancer: Deregulated molecular events and their use as biomarkers.
    Oral Oncol. 2016;61:12-8.
    PubMed     Text format     Abstract available


  68. SCHMIDT H, Kulasinghe A, Kenny L, Punyadeera C, et al
    The development of a liquid biopsy for head and neck cancers.
    Oral Oncol. 2016;61:8-11.
    PubMed     Text format     Abstract available


  69. ADKINS D, Ley J, Michel L, Wildes TM, et al
    nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma.
    Oral Oncol. 2016;61:1-7.
    PubMed     Text format     Abstract available


    September 2016
  70. RANCOULE C, Vallard A, Espenel S, Guy JB, et al
    Immunotherapy in head and neck cancer: Harnessing profit on a system disruption.
    Oral Oncol. 2016 Sep 9. pii: S1368-8375(16)30154.
    PubMed     Text format     Abstract available


  71. BRYAN BELL R, Gough MJ, Seung SK, Jutric Z, et al
    Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy.
    Oral Oncol. 2016 Sep 7. pii: S1368-8375(16)30149.
    PubMed     Text format     Abstract available


  72. MANSHA MA, Abbasi AN, Ali N, Hafiz A, et al
    Correspondence on review article published in Oral Oncology (Vol. 59, August 2016): "Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer."
    Oral Oncol. 2016 Sep 6. pii: S1368-8375(16)30152.
    PubMed     Text format    


  73. LIN Y, Mallen-St Clair J, Wang G, Luo J, et al
    p38 MAPK mediates epithelial-mesenchymal transition by regulating p38IP and Snail in head and neck squamous cell carcinoma.
    Oral Oncol. 2016;60:81-9.
    PubMed     Text format     Abstract available


  74. LEE JY, Suresh K, Nguyen R, Sapir E, et al
    Predictors of severe long-term toxicity after re-irradiation for head and neck cancer.
    Oral Oncol. 2016;60:32-40.
    PubMed     Text format     Abstract available


  75. MADATHIL SA, Rousseau MC, Wynant W, Schlecht NF, et al
    Nonlinear association between betel quid chewing and oral cancer: Implications for prevention.
    Oral Oncol. 2016;60:25-31.
    PubMed     Text format     Abstract available


  76. LU L, Li J, Zhao C, Xue W, et al
    Prognostic efficacy of combining tumor volume with Epstein-Barr virus DNA in patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Oral Oncol. 2016;60:18-24.
    PubMed     Text format     Abstract available


  77. PANDA S, Padhiary SK, Routray S
    Chemokines accentuating protumoral activities in oral cancer microenvironment possess an imperious stratagem for therapeutic resolutions.
    Oral Oncol. 2016;60:8-17.
    PubMed     Text format     Abstract available


  78. CHRISTINA EC, Cornelia C, Edgar S
    Neoadjuvant radiotherapy plus radical surgery for locally advanced stage III/IV oral cancer: Analysis of prognostic factors affecting overall survival.
    Oral Oncol. 2016;60:1-7.
    PubMed     Text format     Abstract available


    August 2016
  79. DASTE A, de Mones E, Dupin C, Francois L, et al
    m-TOR inhibitor as potential radiosensitizer for head and neck squamous cell carcinoma: A case report of an organ transplant patient and review of the literature.
    Oral Oncol. 2016 Aug 30. pii: S1368-8375(16)30136.
    PubMed     Text format    


  80. SZTURZ P, Faivre S
    Letter to the editor referring to the publication entitled "The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment" by Pai et al.
    Oral Oncol. 2016 Aug 28. pii: S1368-8375(16)30135.
    PubMed     Text format    


  81. PAI SI, Zandberg DP, Strome SE
    The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment.
    Oral Oncol. 2016 Aug 5. pii: S1368-8375(16)30119.
    PubMed     Text format     Abstract available


  82. LICITRA L, Keilholz U, Tahara M, Lin JC, et al
    Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer.
    Oral Oncol. 2016;59:73-9.
    PubMed     Text format     Abstract available


  83. RADES D, Seidl D, Janssen S, Bajrovic A, et al
    Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?
    Oral Oncol. 2016;59:67-72.
    PubMed     Text format     Abstract available


  84. NOHATA N, Abba MC, Gutkind JS
    Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection.
    Oral Oncol. 2016;59:58-66.
    PubMed     Text format     Abstract available


  85. OU D, Levy A, Blanchard P, Nguyen F, et al
    Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
    Oral Oncol. 2016;59:50-7.
    PubMed     Text format     Abstract available


  86. OOSTING SF, Chen TW, Huang SH, Wang L, et al
    A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer.
    Oral Oncol. 2016;59:43-9.
    PubMed     Text format     Abstract available


  87. PRINCE ME, Zhou L, Moyer JS, Tao H, et al
    Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
    Oral Oncol. 2016;59:30-42.
    PubMed     Text format     Abstract available


    July 2016
  88. TERENZI V, Cassoni A, Della Monaca M, Priore P, et al
    Oral cancer during pregnancy.
    Oral Oncol. 2016 Jul 2. pii: S1368-8375(16)30092.
    PubMed     Text format    


  89. MICHEL L, Ley J, Wildes TM, Schaffer A, et al
    Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2016;58:41-8.
    PubMed     Text format     Abstract available


  90. WANG K, Amdur RJ, Mendenhall WM, Green R, et al
    Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of life.
    Oral Oncol. 2016;58:21-6.
    PubMed     Text format     Abstract available


  91. SUROV A, Stumpp P, Meyer HJ, Gawlitza M, et al
    Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2016;58:14-20.
    PubMed     Text format     Abstract available


    June 2016
  92. SZTURZ P, Raymond E, Faivre S
    c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside.
    Oral Oncol. 2016 Jun 11. pii: S1368-8375(16)30063.
    PubMed     Text format    


  93. KUO TJ, Ko WT, Chang YC, Lai YC, et al
    Risk of osteoradionecrosis in head and neck cancers: Comparison between oral and non-oral cancers.
    Oral Oncol. 2016 Jun 10. pii: S1368-8375(16)30064.
    PubMed     Text format    


  94. RADES D, Seidl D, Janssen S, Bajrovic A, et al
    Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer?
    Oral Oncol. 2016;57:40-5.
    PubMed     Text format     Abstract available


  95. IQBAL H, Pan Q
    Image guided surgery in the management of head and neck cancer.
    Oral Oncol. 2016;57:32-9.
    PubMed     Text format     Abstract available


  96. RANSOHOFF A, Wood D, Solomon Henry A, Divi V, et al
    Third party assessment of resection margin status in head and neck cancer.
    Oral Oncol. 2016;57:27-31.
    PubMed     Text format     Abstract available


  97. WARD MC, Adelstein DJ, Bhateja P, Nwizu TI, et al
    Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91-11.
    Oral Oncol. 2016;57:21-6.
    PubMed     Text format     Abstract available


    May 2016
  98. T PARSONS J, D Greene B
    Induction chemotherapy for head and neck squamous cell carcinoma.
    Oral Oncol. 2016 May 30. pii: S1368-8375(16)30052.
    PubMed     Text format    


  99. UPPALURI R, Bell RB, Sunwoo JB
    Head and neck cancer immunology and immunotherapeutics: Basic concepts to clinical translational approaches.
    Oral Oncol. 2016 May 26. pii: S1368-8375(16)30050.
    PubMed     Text format    


  100. DAVIS RJ, Van Waes C, Allen CT
    Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.
    Oral Oncol. 2016 May 20. pii: S1368-8375(16)30045.
    PubMed     Text format     Abstract available


  101. HASSONA Y, Abu Ghosh M, Abu Ghlassi T, Scully C, et al
    Public engagement with oral cancer on Facebook.
    Oral Oncol. 2016 May 6. pii: S1368-8375(16)30034.
    PubMed     Text format    


  102. TEPPER SR, Zuo Z, Khattri A, Hess J, et al
    Growth factor expression mediates resistance to EGFR inhibitors in head and neck squamous cell carcinomas.
    Oral Oncol. 2016;56:62-70.
    PubMed     Text format     Abstract available


  103. OOFT ML, van Ipenburg J, Braunius WW, Stegeman I, et al
    A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma.
    Oral Oncol. 2016;56:40-6.
    PubMed     Text format     Abstract available


  104. DATTA J, Islam M, Dutta S, Roy S, et al
    Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs.
    Oral Oncol. 2016;56:32-9.
    PubMed     Text format     Abstract available


  105. LAROCCA CJ, Han J, Salzwedel AO, Davydova J, et al
    Oncolytic adenoviruses targeted to Human Papilloma Virus-positive head and neck squamous cell carcinomas.
    Oral Oncol. 2016;56:25-31.
    PubMed     Text format     Abstract available


  106. DA SILVA JM, Soave DF, Moreira Dos Santos TP, Batista AC, et al
    Significance of chemokine and chemokine receptors in head and neck squamous cell carcinoma: A critical review.
    Oral Oncol. 2016;56:8-16.
    PubMed     Text format     Abstract available


  107. FENG Y, Li Y, Zhang Y, Zheng H, et al
    Association of genetic variants with tumor HPV16 status and survival in squamous cell carcinoma of the oropharynx.
    Oral Oncol. 2016;56:78-83.
    PubMed     Text format     Abstract available


  108. KUO TJ, Leung CM, Chang HS, Wu CN, et al
    Jaw osteoradionecrosis and dental extraction after head and neck radiotherapy: A nationwide population-based retrospective study in Taiwan.
    Oral Oncol. 2016;56:71-7.
    PubMed     Text format     Abstract available


  109. YANG CC, Tu HF, Wu CH, Chang HC, et al
    Up-regulation of HB-EGF by the COX-2/PGE2 signaling associates with the cisplatin resistance and tumor recurrence of advanced HNSCC.
    Oral Oncol. 2016;56:54-61.
    PubMed     Text format     Abstract available


  110. ZAFEREO ME, Xu L, Dahlstrom KR, Viamonte CA, et al
    Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus.
    Oral Oncol. 2016;56:47-53.
    PubMed     Text format     Abstract available


  111. SHARMA S, Bekelman J, Lin A, Lukens JN, et al
    Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2016;56:17-24.
    PubMed     Text format     Abstract available


  112. AMINI A, Jasem J, Jones BL, Robin TP, et al
    Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
    Oral Oncol. 2016;56:1-7.
    PubMed     Text format     Abstract available


    April 2016
  113. ABBOTT D, Cohen E, Sadeghi N, Stein K, et al
    Considering the survivorship care needs of head and neck cancer survivors.
    Oral Oncol. 2016 Apr 26. pii: S1368-8375(16)30032.
    PubMed     Text format    


  114. ETTL T, El-Gindi A, Hautmann M, Gosau M, et al
    Positive frozen section margins predict local recurrence in R0-resected squamous cell carcinoma of the head and neck.
    Oral Oncol. 2016;55:17-23.
    PubMed     Text format     Abstract available


  115. PIERCE CAMPBELL CM, Giuliano AR, Torres BN, O'Keefe MT, et al
    Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.
    Oral Oncol. 2016;55:1-5.
    PubMed     Text format     Abstract available


  116. ROOPER LM, Gandhi M, Bishop JA, Westra WH, et al
    RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Oral Oncol. 2016;55:11-6.
    PubMed     Text format     Abstract available


  117. ELHAKIM MT, Breinholt H, Godballe C, Andersen LJ, et al
    Polymorphous low-grade adenocarcinoma: A Danish national study.
    Oral Oncol. 2016;55:6-10.
    PubMed     Text format     Abstract available


  118. LINARES J, Rullan A, Taberna M, Vazquez S, et al
    Emergence of long-term surviving patients with the introduction of Cetuximab in recurrent/metastatic disease of squamous cell carcinoma of head and neck.
    Oral Oncol. 2016;55:e4.
    PubMed     Text format    


  119. POLEDNAK AP
    Evidence for a stabilization of incidence rates for base of tongue and tonsil carcinoma in the U.S. white population.
    Oral Oncol. 2016;55:e5-6.
    PubMed     Text format    


  120. KANG H, Kwon M, Park JJ, Kim JP, et al
    Clinical implications of human papilloma virus and other biologic markers in nasopharyngeal cancer.
    Oral Oncol. 2016;55:e7-e10.
    PubMed     Text format    


  121. KUK SK, Yoon HJ, Hong SD, Hong SP, et al
    Staging significance of bone invasion in small-sized (4cm or less) oral squamous cell carcinoma as defined by the American Joint Committee on Cancer.
    Oral Oncol. 2016;55:31-6.
    PubMed     Text format     Abstract available


  122. AHN PH, Quon H, O'Malley BW, Weinstein G, et al
    Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors.
    Oral Oncol. 2016;55:37-42.
    PubMed     Text format     Abstract available


  123. HEIDUSCHKA G, Virk SA, Palme CE, Ch'ng S, et al
    Margin to tumor thickness ratio - A predictor of local recurrence and survival in oral squamous cell carcinoma.
    Oral Oncol. 2016;55:49-54.
    PubMed     Text format     Abstract available


    March 2016
  124. PATIL VM, Joshi A, Noronha V, Karpe A, et al
    Technically unresectable recurrent oral cancers: Is NACT the answer?
    Oral Oncol. 2016 Mar 31. pii: S1368-8375(16)30008.
    PubMed     Text format    


  125. HU X, Zhang Q, Hua H, Chen F, et al
    Changes in the salivary microbiota of oral leukoplakia and oral cancer.
    Oral Oncol. 2016 Mar 26. pii: S1368-8375(16)00052.
    PubMed     Text format    


  126. TRZASKOWSKA-KOMON E, Wasiak M, Rolinski J, Klatka J, et al
    Dendritic cells generated from peripheral blood monocytes (Mo-DCs) and stimulated with laryngeal cancer cell lysates are not good enough in stimulating anti-tumor immunity.
    Oral Oncol. 2016 Mar 7. pii: S1368-8375(16)00036.
    PubMed     Text format    


  127. DE FELICE F, Musio D, Tombolini V
    Intra-operative radiation therapy (IORT) in recurrent head and neck cancer.
    Oral Oncol. 2016 Mar 3. pii: S1368-8375(16)00042.
    PubMed     Text format    


  128. GANJRE AP, Sarode GS
    Third hand smoke--A hidden demon.
    Oral Oncol. 2016;54:e3-4.
    PubMed     Text format    


  129. ROWAN NR, Johnson JT, Fratangelo CE, Smith BK, et al
    Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck cancer patients.
    Oral Oncol. 2016;54:42-6.
    PubMed     Text format     Abstract available


  130. SEDGHIZADEH PP, Billington WD, Paxton D, Ebeed R, et al
    Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis.
    Oral Oncol. 2016;54:15-27.
    PubMed     Text format     Abstract available


  131. SHER DJ, Schwartz DL, Nedzi L, Khan S, et al
    Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysis.
    Oral Oncol. 2016;54:58-67.
    PubMed     Text format     Abstract available


  132. OZRETIC L, Wagner S, Huebbers CU, Gattenlohner S, et al
    FGFR1 amplification and co-overexpression of c-MYC in oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2016;54:e7-9.
    PubMed     Text format    


  133. HAHLBROCK A, Goesswein D, Kunzel J, Wunsch D, et al
    Threonine Aspartase1: An unexplored protease with relevance for oral oncology?
    Oral Oncol. 2016;54:e10-2.
    PubMed     Text format    


  134. HOSNI A, Huang SH, Goldstein D, Xu W, et al
    Outcomes and prognostic factors for major salivary gland carcinoma following postoperative radiotherapy.
    Oral Oncol. 2016;54:75-80.
    PubMed     Text format     Abstract available


    February 2016
  135. KRAAIJENGA SA, Oskam IM, van Son RJ, Hamming-Vrieze O, et al
    Assessment of voice, speech, and related quality of life in advanced head and neck cancer patients 10-years+ after chemoradiotherapy.
    Oral Oncol. 2016 Feb 10. pii: S1368-8375(16)00019.
    PubMed     Text format     Abstract available


  136. FIRMINO N, Martinez VD, Rowbotham DA, Enfield KS, et al
    HPV status is associated with altered PIWI-interacting RNA expression pattern in head and neck cancer.
    Oral Oncol. 2016 Feb 4. pii: S1368-8375(16)00015.
    PubMed     Text format     Abstract available


  137. SONIS ST, Hashemi S, Epstein JB, Nair RG, et al
    Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients.
    Oral Oncol. 2016 Feb 3. pii: S1368-8375(16)00008.
    PubMed     Text format     Abstract available


  138. SARODE GS, Sarode SC
    Superficial mucoceles at surgical mucosal margins of excised oral cancer specimens: An unexpected finding.
    Oral Oncol. 2016 Feb 2. pii: S1368-8375(16)00005.
    PubMed     Text format    


  139. HUANG YC, Lee YC, Tseng PH, Chen TC, et al
    Regular screening of esophageal cancer for 248 newly diagnosed hypopharyngeal squamous cell carcinoma by unsedated transnasal esophagogastroduodenoscopy.
    Oral Oncol. 2016 Feb 1. pii: S1368-8375(16)00011.
    PubMed     Text format     Abstract available


  140. YIN ZZ, Gao L, Luo JW, Yi JL, et al
    Long-term outcomes of patients with esthesioneuroblastomas: A cohort from a single institution.
    Oral Oncol. 2016;53:48-53.
    PubMed     Text format     Abstract available


  141. SHRIDHAR K, Walia GK, Aggarwal A, Gulati S, et al
    DNA methylation markers for oral pre-cancer progression: A critical review.
    Oral Oncol. 2016;53:1-9.
    PubMed     Text format     Abstract available


  142. ZHU GA, Lira R, Colevas AD
    Discordance in routine second opinion pathology review of head and neck oncology specimens: A single-center five year retrospective review.
    Oral Oncol. 2016;53:36-41.
    PubMed     Text format     Abstract available


  143. HUNG KF, Liu CJ, Chiu PC, Lin JS, et al
    MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder.
    Oral Oncol. 2016;53:42-7.
    PubMed     Text format     Abstract available


  144. ZHOU X, Su YX, Lao XM, Liang YJ, et al
    CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells.
    Oral Oncol. 2016;53:27-35.
    PubMed     Text format     Abstract available


  145. MUCKE T, Kanatas A, Ritschl LM, Koerdt S, et al
    Tumor thickness and risk of lymph node metastasis in patients with squamous cell carcinoma of the tongue.
    Oral Oncol. 2016;53:80-4.
    PubMed     Text format     Abstract available


    January 2016
  146. DEL FABBRO M, Marcazzan S, D'Antico S, Weinstein RL, et al
    Autologous platelet concentrates in head and neck cancer surgery: Are such bio-adjuvants really safe?
    Oral Oncol. 2016 Jan 25. pii: S1368-8375(16)00012.
    PubMed     Text format    


  147. WALL LR, Cartmill B, Ward EC, Hill AJ, et al
    "ScreenIT": Computerized screening of swallowing, nutrition and distress in head and neck cancer patients during (chemo)radiotherapy.
    Oral Oncol. 2016 Jan 20. pii: S1368-8375(16)00007.
    PubMed     Text format     Abstract available


  148. SHIMANE T, Aizawa H, Koike T, Kamiya M, et al
    Oral cancer intraoperative detection by topically spraying a gamma-glutamyl transpeptidase-activated fluorescent probe.
    Oral Oncol. 2016 Jan 19. pii: S1368-8375(15)00429.
    PubMed     Text format    


  149. ANAND R, Sarode GS, Sarode SC
    Chronic stress and oral cancer research: Disregarded aspects in animal model studies.
    Oral Oncol. 2016 Jan 18. pii: S1368-8375(16)00006.
    PubMed     Text format    


  150. BERGAMINI C, Locati L, Bossi P, Granata R, et al
    Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?
    Oral Oncol. 2016 Jan 13. pii: S1368-8375(16)00002.
    PubMed     Text format     Abstract available


  151. MAZUREK AM, Rutkowski T, Fiszer-Kierzkowska A, Malusecka E, et al
    Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients.
    Oral Oncol. 2016 Jan 11. pii: S1368-8375(15)00428.
    PubMed     Text format     Abstract available


  152. COSWAY B, Lovat P
    The role of autophagy in squamous cell carcinoma of the head and neck.
    Oral Oncol. 2016 Jan 7. pii: S1368-8375(15)00433.
    PubMed     Text format     Abstract available


  153. SAMUELS SE, Tao Y, Lyden T, Haxer M, et al
    Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation.
    Oral Oncol. 2016 Jan 5. pii: S1368-8375(15)00416.
    PubMed     Text format     Abstract available


  154. WEBER M, Iliopoulos C, Moebius P, Buttner-Herold M, et al
    Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas.
    Oral Oncol. 2016;52:75-84.
    PubMed     Text format     Abstract available


  155. LIU JT, Kann BH, De B, Buckstein M, et al
    Prognostic value of radiographic extracapsular extension in locally advanced head and neck squamous cell cancers.
    Oral Oncol. 2016;52:52-7.
    PubMed     Text format     Abstract available


  156. KESHET N, Abu-Tair J, Zaharia B, Abdalla-Aslan R, et al
    Superficial oral mucoceles in cancer patient after radiation therapy: An overlooked yet imperative phenomenon.
    Oral Oncol. 2016;52:e1-2.
    PubMed     Text format    


  157. GUO T, Rettig E, Fakhry C
    Understanding the impact of survival and human papillomavirus tumor status on timing of recurrence in oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2016;52:97-103.
    PubMed     Text format     Abstract available


  158. VAN MONSJOU HS, Schaapveld M, Hamming-Vrieze O, de Boer JP, et al
    Cause-specific excess mortality in patients treated for cancer of the oral cavity and oropharynx: A population-based study.
    Oral Oncol. 2016;52:37-44.
    PubMed     Text format     Abstract available


  159. SCHWAM ZG, Judson BL
    Improved prognosis for patients with oral cavity squamous cell carcinoma: Analysis of the National Cancer Database 1998-2006.
    Oral Oncol. 2016;52:45-51.
    PubMed     Text format     Abstract available


  160. YU V, Rahimy M, Korrapati A, Xuan Y, et al
    Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines.
    Oral Oncol. 2016;52:58-65.
    PubMed     Text format     Abstract available


  161. ZHAN KY, Nicolli EA, Khaja SF, Day TA, et al
    Lymphoepithelial carcinoma of the major salivary glands: Predictors of survival in a non-endemic region.
    Oral Oncol. 2016;52:24-9.
    PubMed     Text format     Abstract available


    December 2015
  162. GEIGER JL, Grandis JR, Bauman JE
    The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.
    Oral Oncol. 2015 Dec 27. pii: S1368-8375(15)00412.
    PubMed     Text format     Abstract available


  163. AHN MJ, D'Cruz A, Vermorken JB, Chen JP, et al
    Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review.
    Oral Oncol. 2015 Dec 19. pii: S1368-8375(15)00397.
    PubMed     Text format     Abstract available


  164. WOODY NM, Koyfman SA, Xia P, Yu N, et al
    Regional control is preserved after dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancer.
    Oral Oncol. 2015 Dec 17. pii: S1368-8375(15)00370.
    PubMed     Text format     Abstract available


  165. BOWLES DW, Keysar SB, Eagles JR, Wang G, et al
    A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2015 Dec 15. pii: S1368-8375(15)00392.
    PubMed     Text format     Abstract available


  166. CHUNG CH, Rudek MA, Kang H, Marur S, et al
    A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma.
    Oral Oncol. 2015 Dec 15. pii: S1368-8375(15)00398.
    PubMed     Text format     Abstract available


  167. GALVAO-MOREIRA LV, da Cruz MC
    Oral microbiome, periodontitis and risk of head and neck cancer.
    Oral Oncol. 2015 Dec 10. pii: S1368-8375(15)00391.
    PubMed     Text format     Abstract available


  168. LEE MS, Nelson AM, Thompson LM, Donovan KA, et al
    Supportive care needs of oral cancer survivors: Prevalence and correlates.
    Oral Oncol. 2015 Dec 9. pii: S1368-8375(15)00385.
    PubMed     Text format     Abstract available


  169. SETTON J, Han J, Kannarunimit D, Wuu YR, et al
    Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma.
    Oral Oncol. 2015 Dec 7. pii: S1368-8375(15)00393.
    PubMed     Text format     Abstract available


    November 2015
  170. VAN DER LINDEN N, Flach GB, de Bree R, Uyl-de Groot CA, et al
    Cost-utility of sentinel lymph node biopsy in cT1-T2N0 oral cancer.
    Oral Oncol. 2015 Nov 26. pii: S1368-8375(15)00389.
    PubMed     Text format     Abstract available


  171. BELL RB, Leidner RS, Crittenden MR, Curti BD, et al
    OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironment.
    Oral Oncol. 2015 Nov 21. pii: S1368-8375(15)00387.
    PubMed     Text format     Abstract available


  172. CHANG JW, Gwak SY, Shim GA, Liu L, et al
    EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
    Oral Oncol. 2015 Nov 18. pii: S1368-8375(15)00368.
    PubMed     Text format     Abstract available


  173. RYLANDS J, Lowe D, Rogers SN
    Outcomes by area of residence deprivation in a cohort of oral cancer patients: Survival, health-related quality of life, and place of death.
    Oral Oncol. 2015 Nov 12. pii: S1368-8375(15)00361.
    PubMed     Text format     Abstract available


  174. LICITRA L, Mesia R, Keilholz U
    Individualised quality of life as a measure to guide treatment choices in squamous cell carcinoma of the head and neck.
    Oral Oncol. 2015 Nov 11. pii: S1368-8375(15)00364.
    PubMed     Text format     Abstract available


  175. PEDERSEN A, Wilson J, McColl E, Carding P, et al
    Swallowing outcome measures in head and neck cancer - How do they compare?
    Oral Oncol. 2015 Nov 9. pii: S1368-8375(15)00359.
    PubMed     Text format     Abstract available


  176. LANGIUS JA, Twisk J, Kampman M, Doornaert P, et al
    Prediction model to predict critical weight loss in patients with head and neck cancer during (chemo)radiotherapy.
    Oral Oncol. 2015 Nov 9. pii: S1368-8375(15)00365.
    PubMed     Text format     Abstract available


  177. ANTUNES HS, Schluckebier LF, Herchenhorn D, Small IA, et al
    Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation.
    Oral Oncol. 2015 Nov 7. pii: S1368-8375(15)00366.
    PubMed     Text format     Abstract available


  178. WEI J, Pei S, Zhu X
    Comparison of (18)F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
    Oral Oncol. 2015 Nov 4. pii: S1368-8375(15)00354.
    PubMed     Text format     Abstract available


  179. GALVAO-MOREIRA LV, da Cruz MC
    Dental demineralization, radiation caries and oral microbiota in patients with head and neck cancer.
    Oral Oncol. 2015 Nov 2. pii: S1368-8375(15)00352.
    PubMed     Text format    


  180. DE FELICE F, Thomas C, Barrington S, Pathmanathan A, et al
    Analysis of loco-regional failures in head and neck cancer after radical radiation therapy.
    Oral Oncol. 2015;51:1051-5.
    PubMed     Text format     Abstract available


    October 2015
  181. LI S, Lee YA, Li Q, Chen CJ, et al
    Oral lesions, chronic diseases and the risk of head and neck cancer.
    Oral Oncol. 2015 Oct 29. pii: S1368-8375(15)00358.
    PubMed     Text format     Abstract available


  182. TAKES RP, Wierzbicka M, D'Souza G, Jackowska J, et al
    HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?
    Oral Oncol. 2015 Oct 28. pii: S1368-8375(15)00355.
    PubMed     Text format     Abstract available


  183. LIANG L, Zhang T, Kong Q, Liang J, et al
    A meta-analysis on selective versus comprehensive neck dissection in oral squamous cell carcinoma patients with clinically node-positive neck.
    Oral Oncol. 2015 Oct 20. pii: S1368-8375(15)00335.
    PubMed     Text format     Abstract available


  184. BJORNDAL K, Krogdahl A, Therkildsen MH, Charabi B, et al
    Salivary adenoid cystic carcinoma in Denmark 1990-2005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA).
    Oral Oncol. 2015 Oct 14. pii: S1368-8375(15)00332.
    PubMed     Text format     Abstract available


  185. POLLOM EL, Wang E, Bui TT, Ognibene G, et al
    A prospective study of electronic quality of life assessment using tablet devices during and after treatment of head and neck cancers.
    Oral Oncol. 2015 Oct 13. pii: S1368-8375(15)00333.
    PubMed     Text format     Abstract available


  186. LEE YS, Park JY, Cho KJ, Kim SB, et al
    Composition of inflammatory cells regulating the response to concurrent chemoradiation therapy for HPV (+) tonsil cancer.
    Oral Oncol. 2015 Oct 13. pii: S1368-8375(15)00331.
    PubMed     Text format     Abstract available


    September 2015
  187. D'SOUZA W, Saranath D
    Clinical implications of epigenetic regulation in oral cancer.
    Oral Oncol. 2015 Sep 25. pii: S1368-8375(15)00326.
    PubMed     Text format     Abstract available


  188. RAMQVIST T, Mints M, Tertipis N, Nasman A, et al
    Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters.
    Oral Oncol. 2015 Sep 25. pii: S1368-8375(15)00327.
    PubMed     Text format     Abstract available


  189. PRASANNA R, Balan A, Radhakrishna Pillai M
    Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer.
    Oral Oncol. 2015 Sep 22. pii: S1368-8375(15)00318.
    PubMed     Text format    


  190. DE FELICE F, Musio D, Tombolini V
    Target volume delineation after induction chemotherapy in locally advanced head and neck cancer.
    Oral Oncol. 2015 Sep 16. pii: S1368-8375(15)00325.
    PubMed     Text format    


  191. DE BREE R, van den Brekel MW
    Elective neck dissection versus observation in the clinically node negative neck in early oral cancer: Do we have the answer yet?
    Oral Oncol. 2015 Sep 15. pii: S1368-8375(15)00316.
    PubMed     Text format    


  192. JOHNSON-OBASEKI S, Kelly K, Corsten M
    Response to: "No evidence for improved TORS post-treatment feeding tube dependency rate relative to standard therapy in early stage oropharyngeal cancer".
    Oral Oncol. 2015;51:e68.
    PubMed     Text format    


  193. RINGASH J, Huang SH, Waldron J, O'Sullivan B, et al
    No evidence for improved TORS post-treatment feeding tube dependency rate relative to standard therapy in early stage oropharyngeal cancer.
    Oral Oncol. 2015;51:e67.
    PubMed     Text format    


    August 2015
  194. REN ZH, Xu JL, Li B, Fan TF, et al
    Elective versus therapeutic neck dissection in node-negative oral cancer: Evidence from five randomized controlled trials.
    Oral Oncol. 2015 Aug 25. pii: S1368-8375(15)00299.
    PubMed     Text format     Abstract available


  195. XIE H, Li C, He Y, Griffin R, et al
    Chronic stress promotes oral cancer growth and angiogenesis with increased circulating catecholamine and glucocorticoid levels in a mouse model.
    Oral Oncol. 2015 Aug 24. pii: S1368-8375(15)00297.
    PubMed     Text format     Abstract available


  196. AL TAMIMI AS, Zaheer S, Ng DC, Osmany S, et al
    The incidence and sites of Nasopharyngeal carcinoma (NPC) metastases on FDG PET/CT scans.
    Oral Oncol. 2015 Aug 24. pii: S1368-8375(15)00291.
    PubMed     Text format     Abstract available


  197. LIN Y, Clair JM, Luo J, Sharma S, et al
    p53 modulates NF-kappaB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
    Oral Oncol. 2015 Aug 22. pii: S1368-8375(15)00270.
    PubMed     Text format     Abstract available


  198. ZHANG B, Mo Z, Du W, Wang Y, et al
    Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Oral Oncol. 2015 Aug 18. pii: S1368-8375(15)00295.
    PubMed     Text format     Abstract available


    July 2015
  199. VAN MONSJOU HS, Schaapveld M, van den Brekel MW, Balm AJ, et al
    The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
    Oral Oncol. 2015 Jul 24. pii: S1368-8375(15)00258.
    PubMed     Text format     Abstract available


  200. RATHOD S, Livergant J, Klein J, Witterick I, et al
    A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatment.
    Oral Oncol. 2015 Jul 21. pii: S1368-8375(15)00266.
    PubMed     Text format     Abstract available


  201. ZHANG LN, Gao YH, Lan XW, Tang J, et al
    Effect of taxanes-based induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A large scale propensity-matched study.
    Oral Oncol. 2015 Jul 21. pii: S1368-8375(15)00268.
    PubMed     Text format     Abstract available


  202. DENG J, Jackson L, Epstein JB, Migliorati CA, et al
    Dental demineralization and caries in patients with head and neck cancer.
    Oral Oncol. 2015 Jul 18. pii: S1368-8375(15)00256.
    PubMed     Text format     Abstract available


  203. LI YY, Zhou CX, Gao Y
    Moesin regulates the motility of oral cancer cells via MT1-MMP and E-cadherin/p120-catenin adhesion complex.
    Oral Oncol. 2015 Jul 17. pii: S1368-8375(15)00267.
    PubMed     Text format     Abstract available


  204. LIU SZ, Zandberg DP, Schumaker LM, Papadimitriou JC, et al
    Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancer.
    Oral Oncol. 2015 Jul 13. pii: S1368-8375(15)00263.
    PubMed     Text format     Abstract available


  205. GUERRA EN, Acevedo AC, Leite AF, Gozal D, et al
    Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: A systematic review and meta-analysis.
    Oral Oncol. 2015 Jul 10. pii: S1368-8375(15)00257.
    PubMed     Text format     Abstract available


  206. HITCHCOCK KE, Amdur RJ, Mendenhall WM, Werning JW, et al
    Lessons from a standardized program using PET-CT to avoid neck dissection after primary radiotherapy for N2 squamous cell carcinoma of the oropharynx.
    Oral Oncol. 2015 Jul 8. pii: S1368-8375(15)00261.
    PubMed     Text format     Abstract available


  207. XU T, Liu Y, Dou S, Li F, et al
    Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study.
    Oral Oncol. 2015 Jul 7. pii: S1368-8375(15)00255.
    PubMed     Text format     Abstract available


    June 2015
  208. DE BREE R, Nieweg OE
    The history of sentinel node biopsy in head and neck cancer: From visualization of lymphatic vessels to sentinel nodes.
    Oral Oncol. 2015 Jun 27. pii: S1368-8375(15)00240.
    PubMed     Text format     Abstract available


  209. DALIANIS T, Grun N, Koch J, Vlastos A, et al
    Human papillomavirus DNA and p16 expression in hypopharyngeal cancer and in relation to clinical outcome, in Stockholm, Sweden.
    Oral Oncol. 2015 Jun 25. pii: S1368-8375(15)00236.
    PubMed     Text format     Abstract available


  210. DAHLSTROM KR, Bell D, Hanby D, Li G, et al
    Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
    Oral Oncol. 2015 Jun 25. pii: S1368-8375(15)00239.
    PubMed     Text format     Abstract available


  211. ANDERSON KS, Gerber JE, D'Souza G, Pai SI, et al
    Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.
    Oral Oncol. 2015 Jun 18. pii: S1368-8375(15)00229.
    PubMed     Text format     Abstract available


  212. CHAWLA JP, Iyer N, Soodan KS, Sharma A, et al
    Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer.
    Oral Oncol. 2015 Jun 17. pii: S1368-8375(15)00230.
    PubMed     Text format     Abstract available


  213. JIN BJ, Kim MK, Ji YB, Song CM, et al
    Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma.
    Oral Oncol. 2015 Jun 17. pii: S1368-8375(15)00232.
    PubMed     Text format     Abstract available


  214. YOUNG D, Xiao CC, Murphy B, Moore M, et al
    Increase in head and neck cancer in younger patients due to human papillomavirus (HPV).
    Oral Oncol. 2015 Jun 8. pii: S1368-8375(15)00182.
    PubMed     Text format     Abstract available


  215. SCHERPENHUIZEN A, van Waes AM, Janssen LM, Van Cann EM, et al
    The effect of exercise therapy in head and neck cancer patients in the treatment of radiotherapy-induced trismus: A systematic review.
    Oral Oncol. 2015 Jun 6. pii: S1368-8375(15)00208.
    PubMed     Text format     Abstract available


  216. TABERNA M, Rullan AJ, Hierro C, Navarro V, et al
    Late toxicity after radical treatment for locally advanced head and neck cancer.
    Oral Oncol. 2015 Jun 4. pii: S1368-8375(15)00209.
    PubMed     Text format     Abstract available


  217. SONG Y, Wang W, Tao G, Zhou X, et al
    Survival benefit of induction chemotherapy in treatment for locally advanced nasopharyngeal carcinoma - A time-to-event meta-analysis.
    Oral Oncol. 2015 Jun 3. pii: S1368-8375(15)00226.
    PubMed     Text format     Abstract available


  218. DUAN H, Gamper E, Becherer A, Hoffmann M, et al
    Quality of life aspects in the management of thyroid cancer.
    Oral Oncol. 2015;51:S1-5.
    PubMed     Text format     Abstract available


  219. DAN TD, Raben D, Schneider CJ, Hockstein NG, et al
    Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: updated results of an institutional clinical management approach.
    Oral Oncol. 2015;51:616-21.
    PubMed     Text format     Abstract available


  220. JOSEPH LJ, Goodman M, Higgins K, Pilai R, et al
    Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis.
    Oral Oncol. 2015;51:586-92.
    PubMed     Text format     Abstract available


  221. MASON M, Giuliani M, Huang SH, Xu W, et al
    Extra-pulmonary small cell carcinoma in the head and neck setting: the role of prophylactic cranial irradiation.
    Oral Oncol. 2015;51:e57-9.
    PubMed     Text format     Abstract available


  222. ZHANG H, Dziegielewski PT, Jean Nguyen TT, Jeffery CC, et al
    The effects of geography on survival in patients with oral cavity squamous cell carcinoma.
    Oral Oncol. 2015;51:578-85.
    PubMed     Text format     Abstract available


  223. HUANG AT, Tang C, Bell D, Yener M, et al
    Prognostic factors in adenocarcinoma of the salivary glands.
    Oral Oncol. 2015;51:610-5.
    PubMed     Text format     Abstract available


    May 2015
  224. KRAAIJENGA SA, Oskam IM, van der Molen L, Hamming-Vrieze O, et al
    Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer.
    Oral Oncol. 2015 May 28. pii: S1368-8375(15)00210.
    PubMed     Text format     Abstract available


  225. ZUMSTEG ZS, Riaz N, Jaffery S, Hu M, et al
    Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.
    Oral Oncol. 2015 May 7. pii: S1368-8375(15)00034.
    PubMed     Text format     Abstract available


  226. ANDERSON KS, Dahlstrom KR, Cheng JN, Alam R, et al
    HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
    Oral Oncol. 2015 May 6. pii: S1368-8375(15)00186.
    PubMed     Text format     Abstract available


  227. YANG W, Men Y, Li C
    Can meta-analysis be replaced by best-evidence synthesis in oral oncology systematic review?
    Oral Oncol. 2015;51:e21.
    PubMed     Text format    


  228. ZEIDAN YH, Pekelis L, An Y, Holsinger FC, et al
    Survival benefit for adjuvant radiation therapy in minor salivary gland cancers.
    Oral Oncol. 2015;51:438-45.
    PubMed     Text format     Abstract available


  229. SINHA P, Kallogjeri D, Gay H, Thorstad WL, et al
    High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer.
    Oral Oncol. 2015;51:514-20.
    PubMed     Text format     Abstract available


  230. CHEN TC, Wu CT, Wang CP, Yang TL, et al
    Significance of nuclear p-mTOR expression in advanced oral squamous cell carcinoma with extracapsular extension of lymph node metastases.
    Oral Oncol. 2015;51:493-9.
    PubMed     Text format     Abstract available


  231. XUELEI M, Jingwen H, Wei D, Hongyu Z, et al
    ERCC1 plays an important role in predicting survival outcomes and treatment response for patients with HNSCC: a meta-analysis.
    Oral Oncol. 2015;51:483-92.
    PubMed     Text format     Abstract available


  232. ANDERSON CR, Sisson K, Moncrieff M
    A meta-analysis of margin size and local recurrence in oral squamous cell carcinoma.
    Oral Oncol. 2015;51:464-9.
    PubMed     Text format     Abstract available


  233. DENG J, Ridner SH, Aulino JM, Murphy BA, et al
    Assessment and measurement of head and neck lymphedema: state-of-the-science and future directions.
    Oral Oncol. 2015;51:431-7.
    PubMed     Text format     Abstract available


  234. JEGU J, Belot A, Borel C, Daubisse-Marliac L, et al
    Effect of previous history of cancer on survival of patients with a second cancer of the head and neck.
    Oral Oncol. 2015;51:457-63.
    PubMed     Text format     Abstract available


    April 2015
  235. LEVY A, Leboulleux S, Lepoutre-Lussey C, Baudin E, et al
    (18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer.
    Oral Oncol. 2015;51:370-5.
    PubMed     Text format     Abstract available


  236. JIMENO A, Bauman JE, Weissman C, Adkins D, et al
    A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer.
    Oral Oncol. 2015;51:383-8.
    PubMed     Text format     Abstract available


  237. MALI SB
    Stereotactic radiotherapy for head neck cancer.
    Oral Oncol. 2015;51:e19-20.
    PubMed     Text format    


  238. WANG W, Lim WK, Leong HS, Chong FT, et al
    An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.
    Oral Oncol. 2015;51:355-62.
    PubMed     Text format     Abstract available


    March 2015
  239. PATIL VM, Noronha V, Joshi A, Muddu VK, et al
    A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck.
    Oral Oncol. 2015;51:279-86.
    PubMed     Text format     Abstract available


  240. SAEED AA, Sims AH, Prime SS, Paterson I, et al
    Gene expression profiling reveals biological pathways responsible for phenotypic heterogeneity between UK and Sri Lankan oral squamous cell carcinomas.
    Oral Oncol. 2015;51:237-46.
    PubMed     Text format     Abstract available


  241. RITPRAJAK P, Azuma M
    Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma.
    Oral Oncol. 2015;51:221-8.
    PubMed     Text format     Abstract available


  242. MIRGHANI H, Amen F, Moreau F, Lacau St Guily J, et al
    Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma?
    Oral Oncol. 2015;51:229-36.
    PubMed     Text format     Abstract available


    February 2015
  243. ADKINS D, Ley J, Michel L, Wildes TM, et al
    Looking beyond the CRT paradigm: why induction chemotherapy is worthy of pursuit.
    Oral Oncol. 2015;51:103-4.
    PubMed     Text format    


  244. DE ALMEIDA FC, Moreira MS, Cazal C, Araujo ME, et al
    Reply to "The symbolic value of prostheses in maxillofacial rehabilitation".
    Oral Oncol. 2015;51:e13.
    PubMed     Text format    


  245. ETTL T, Viale-Bouroncle S, Hautmann MG, Gosau M, et al
    AKT and MET signalling mediates antiapoptotic radioresistance in head neck cancer cell lines.
    Oral Oncol. 2015;51:158-63.
    PubMed     Text format     Abstract available


  246. MOCHIZUKI Y, Harada H, Ikuta M, Shimamoto H, et al
    Clinical characteristics of multiple primary carcinomas of the oral cavity.
    Oral Oncol. 2015;51:182-9.
    PubMed     Text format     Abstract available


  247. OHMAN J, Rexius H, Mjornstedt L, Gonzalez H, et al
    Oral and lip cancer in solid organ transplant patients--a cohort study from a Swedish Transplant Centre.
    Oral Oncol. 2015;51:146-50.
    PubMed     Text format     Abstract available


  248. TSAI WC, Kung PT, Wang ST, Huang KH, et al
    Beneficial impact of multidisciplinary team management on the survival in different stages of oral cavity cancer patients: results of a nationwide cohort study in Taiwan.
    Oral Oncol. 2015;51:105-11.
    PubMed     Text format     Abstract available


  249. GOMES CC, Fonseca-Silva T, Galvao CF, Friedman E, et al
    Inter- and intra-lesional molecular heterogeneity of oral leukoplakia.
    Oral Oncol. 2015;51:178-81.
    PubMed     Text format     Abstract available


  250. FOTOPOULOS G, Pavlidis N
    The role of human papilloma virus and p16 in occult primary of the head and neck: a comprehensive review of the literature.
    Oral Oncol. 2015;51:119-23.
    PubMed     Text format     Abstract available


  251. MALI SB
    Proton therapy for head neck cancer.
    Oral Oncol. 2015;51:e10-2.
    PubMed     Text format    


  252. TANG C, Fuller CD, Garden AS, Awan MJ, et al
    Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response.
    Oral Oncol. 2015;51:195-201.
    PubMed     Text format     Abstract available


  253. YANG CN, Deng YT, Tang JY, Cheng SJ, et al
    MicroRNA-29b regulates migration in oral squamous cell carcinoma and its clinical significance.
    Oral Oncol. 2015;51:170-7.
    PubMed     Text format     Abstract available


    January 2015
  254. SARODE SC, Sarode GS
    Oral squamous cell carcinoma prone disorders/individuals.
    Oral Oncol. 2015;51:e4.
    PubMed     Text format    


  255. XIAO X, Shi L, Li H, Song Y, et al
    DNA content status using brush biopsy with image cytometry correlated with staging of oral leukoplakia: a preliminary study.
    Oral Oncol. 2015;51:59-63.
    PubMed     Text format     Abstract available


  256. SWANSON MS, Sinha UK
    Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer-review of current data.
    Oral Oncol. 2015;51:12-5.
    PubMed     Text format     Abstract available


  257. VAN WEERT S, van der Waal I, Witte BI, Leemans CR, et al
    Histopathological grading of adenoid cystic carcinoma of the head and neck: analysis of currently used grading systems and proposal for a simplified grading scheme.
    Oral Oncol. 2015;51:71-6.
    PubMed     Text format     Abstract available


  258. LEE YS, Lim YS, Lee JC, Wang SG, et al
    Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer.
    Oral Oncol. 2015;51:77-83.
    PubMed     Text format     Abstract available


  259. MORIYA Y, Uzawa N, Morita T, Mogushi K, et al
    The high-temperature requirement factor A3 (HtrA3) is associated with acquisition of the invasive phenotype in oral squamous cell carcinoma cells.
    Oral Oncol. 2015;51:84-9.
    PubMed     Text format     Abstract available


  260. JIA S, Wang W, Hu Z, Shan C, et al
    BDNF mediated TrkB activation contributes to the EMT progression and the poor prognosis in human salivary adenoid cystic carcinoma.
    Oral Oncol. 2015;51:64-70.
    PubMed     Text format     Abstract available


  261. WOLF GT, Chepeha DB, Bellile E, Nguyen A, et al
    Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study.
    Oral Oncol. 2015;51:90-5.
    PubMed     Text format     Abstract available


  262. MAKINEN LK, Atula T, Hayry V, Jouhi L, et al
    Predictive role of Toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma.
    Oral Oncol. 2015;51:96-102.
    PubMed     Text format     Abstract available


    December 2014
  263. JENKINS WD, LeVault K, Sutcliffe S
    Chlamydia trachomatis infection: Possible cofactor for oropharyngeal cancer development?
    Oral Oncol. 2014 Dec 11. pii: S1368-8375(14)00354.
    PubMed     Text format    


  264. ADKINS D, Ley J
    Response to: 'Pre-medications for cetuximab induced infusion reactions - commentary'.
    Oral Oncol. 2014;50:e72.
    PubMed     Text format    


  265. DE ALMEIDA FC, Moreira MS, Araujo ME, da Silva DP, et al
    The symbolic value of prostheses in maxillofacial rehabilitation.
    Oral Oncol. 2014;50:e69-70.
    PubMed     Text format    


  266. MCKIBBIN T, Donald Harvey R, Saba NF
    Pre-medications for cetuximab induced infusion reactions - commentary.
    Oral Oncol. 2014;50:e71.
    PubMed     Text format    


    November 2014
  267. FARAH CS
    Response to: 'the many generations of sequencing technology'.
    Oral Oncol. 2014;50:e62.
    PubMed     Text format    


  268. SETHI N, Wood H, Rabbitts P
    The many generations of sequencing technology.
    Oral Oncol. 2014;50:e61.
    PubMed     Text format    


    October 2014
  269. GOLDENBERG D, Mackley H, Koch W, Bann DV, et al
    Age and stage as determinants of treatment for oral cavity and oropharyngeal cancers in the elderly.
    Oral Oncol. 2014;50:976-82.
    PubMed     Text format     Abstract available


  270. FAN JH, Wang JB, Qu CX, Zhang YQ, et al
    Association between oral leukoplakia and upper gastrointestinal cancers: a 28-year follow-up study in the Linxian General Population Trial.
    Oral Oncol. 2014;50:971-5.
    PubMed     Text format     Abstract available


  271. SLOT DE, Van der Weijden F, Ciancio SG
    Oral health, dental care and mouthwash associated with upper aerodigestive tract cancer risk in Europe: the ARCAGE study.
    Oral Oncol. 2014;50:e57.
    PubMed     Text format    


  272. PATIL VM, Prabhash K, Noronha V, Joshi A, et al
    Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers.
    Oral Oncol. 2014;50:1000-4.
    PubMed     Text format     Abstract available


  273. SARODE SC, Sarode GS, Patil S
    Role of statherin in oral carcinogenesis.
    Oral Oncol. 2014;50:e55-6.
    PubMed     Text format    


  274. BHATIA N, Matias MA, Farah CS
    Assessment of a decision making protocol to improve the efficacy of VELscope in general dental practice: a prospective evaluation.
    Oral Oncol. 2014;50:1012-9.
    PubMed     Text format     Abstract available


  275. SATHEESHKUMAR PS, Mohan MP
    Necessitating a quality of life instrument specific to oral precancers/oral potentially malignant disorders.
    Oral Oncol. 2014;50:e51.
    PubMed     Text format    


  276. WENG J, Wang C, Wang Y, Tang H, et al
    Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines.
    Oral Oncol. 2014;50:983-90.
    PubMed     Text format     Abstract available


  277. LI J, Perlaky L, Rao P, Weber RS, et al
    Development and characterization of salivary adenoid cystic carcinoma cell line.
    Oral Oncol. 2014;50:991-9.
    PubMed     Text format     Abstract available


    August 2014
  278. DAVIS KS, Vargo JA, Ferris RL, Burton SA, et al
    Stereotactic body radiotherapy for recurrent oropharyngeal cancer - Influence of HPV status and smoking history.
    Oral Oncol. 2014 Aug 28. pii: S1368-8375(14)00238.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: